Phase III Clinical Trial of STSP-0601 for Injection in Hemophilia Patients
Conditions
Hemophilia
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Anhui Provincial Hospital, Hefei, Anhui, China
Lanzhou University First Hospital, Lanzhou, Gansu, China
Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China
Shenzhen Second People's Hospital, Shenzhen, Guangdong, China
The First affiliated hospital of Guangxi Medical University, Nanning, Guangxi, China
North China University of Science and Technology Affiliated Hospital, Tangshan, Hebei, China
Harbin First Hospital Hematology Tumor Research Center, Harbin, Heilongjiang, China
Henan Cancer Hospital, Zhengzhou, Henan, China
Huazhong University of Science and Technology Union Hospital, Wuhan, Hubei, China
Jiangsu Provincial Hospital, Nanjing, Jiangsu, China
The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
Jinan Central Clinical College of Shandong First Medical University, Jinan, Shandong, China
Second hospital of Shanxi Medical University, Taiyuan, Shanxi, China
Xi'an Central Hospital, Xi’an, Shanxi, China
Sichuan Academy of Medical Sciences＆Sichuan Provincial People's Hospital, Chengdu, Sichuan, China
Hospital of Hematology, Chinese Academy of Medical Sciences, Tianjin, Tianjin Municipality, China
The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China
Wenzhou People's Hospital, Wenzhou, Zhejiang, China
Study leads
Lei Zhang, Ph.D
Principal Investigator
Hospital of Hematology, Chinese Academy of Medical Sciences